Could a cancer drug fix an irregular heartbeat?
NCT ID NCT03298321
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether Vidaza, a drug used for acute leukemia, could also help treat atrial fibrillation (an irregular heartbeat). The idea was that Vidaza might reverse certain DNA changes that lower the activity of a gene important for heart function. Only one person took part, and researchers tracked heart rhythm and heart structure changes over 6 to 12 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Léon Berard
Lyon, 69008, France
-
Hopital Lyon Sud
Pierre-Bénite, 69310, France
-
Service de rythmologie - GH Est-Hôpital Louis Pradel - CHU de Lyon HCL
Bron, 69229, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- A tiny neck implant could catch Stroke-Causing clots before they reach the brain
- Could a bigger balloon tame the Heart's electrical chaos?
- Could a new injection tame atrial fibrillation?
- Can a new heart ablation technique work without x-rays?
- Which blood thinner is safer for heart patients? a Head-to-Head test